|Long-Term Follow Up Pinpoints Side Effects of Treatments for Prostate Cancer Patients
A 10-year follow-up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision-making in terms of treatments and side effects for a diverse population. The CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation for Localized Prostate Cancer) study, coordinated by VUMC, is a multisite research study conducting long-term follow-up on men who were diagnosed with localized prostate cancer between 2011 and 2012.
Thursday, February 1st, 2024
|VUMC to help engage more study participants in research decisions
Human research will be more equitable, inclusive and stronger if the people who are participants in studies also help plan and guide the direction of those studies.
Wednesday, October 25th, 2023
|VUMC initiative to address social drivers of health
Vanderbilt University Medical Center has received a federal grant to incorporate social drivers of health into adult primary care with the aim of improving outcomes for patients with multiple chronic conditions.
Thursday, October 19th, 2023
|Karen Winkfield named a fellow of the American Society for Radiation Oncology
Karen Winkfield, MD, PhD, executive director of the Meharry-Vanderbilt Alliance, has been named a fellow of the American Society for Radiation Oncology.
Tuesday, August 1st, 2023
|Winkfield to direct Meharry-Vanderbilt Alliance
Friday, September 3rd, 2021
|Study finds AI can categorize cancer risk of lung nodules
Computed tomography scans for people at risk for lung cancer lead to earlier diagnoses and improve survival rates, but they can also lead to overtreatment when suspicious nodules turn out to be benign.
Thursday, May 7th, 2020
|Study tracks genomics of lung tumor behavior
A study by Vanderbilt researchers has identified genomic alterations in early stage adenocarcinomas of the lung that may indicate whether the lesions develop into aggressive tumors.
Thursday, April 9th, 2020
|Study examines prostate cancer treatment decisions
A five-year follow-up study of U.S. men who received prostate cancer treatment is creating a road map for future patients to clarify expectations and enable men to make informed choices about care.
Friday, January 3rd, 2020
|VUMC’s Osterman awarded Microsoft Investigator Fellowship
Travis Osterman, DO, MS, has been awarded a Microsoft Investigator Fellowship.
Thursday, November 7th, 2019
|Study examines pain processing in co-occurring cancer, Alzheimer’s disease
A new multisite study will examine whether co-occurring Alzheimer’s disease and stage 4 breast or prostate cancer alters pain perception, potentially leading to undertreated cancer pain.
Thursday, October 10th, 2019
|Effort seeks to enhance cancer screening for Hispanic/Latina women
Wednesday, September 25th, 2019
|New telehealth initiative aims to enhance cancer care in rural areas
Thursday, September 19th, 2019
|Academic Pediatric Association honors Barkin
Shari Barkin, MD, MSHS, division chief of General Pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt, was honored recently with the 2019 Academic Pediatric Association (APA) Research Award.
Thursday, May 30th, 2019
|Technology better than tape measure for identifying lymphedema risk
Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery, according to interim results of a recent study.
Friday, May 17th, 2019
|Grant to develop ways to measure medical mistrust in African-American men
Friday, August 3rd, 2018
|Wilkins takes key role in national ‘All of Us’ precision medicine effort
Monday, April 30th, 2018
|New prostate cancer therapy investigated at VUMC
Thursday, September 22nd, 2016